Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ALLURION TECHNOLOGIES, INC.

Get SEC filing alerts via email and in your feed for ALLURION TECHNOLOGIES, INC.

ALUR ALUR-WT

ALLURION TECHNOLOGIES, INC.

About ALLURION TECHNOLOGIES, INC.

Allurion Technologies, Inc. is a medical device company focused on combating obesity through its innovative Allurion Program, which features the swallowable, Procedureless™ intragastric balloon for weight loss. Targeting the $54 billion global obesity treatment market, Allurion aims to serve over 10 million potential U.S. patients. The company enhances patient outcomes with AI-powered remote monitoring and behavior change tools, while expanding its offerings to include weight loss medications and combination therapies.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ALLURION TECHNOLOGIES, INC.

1
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 47% Revenue Decline and $6.1 Million Net Loss in Q1 2026

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 53% Revenue Decline, Receives FDA Approval for Gastric Balloon System

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 50% Revenue Decline in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 71% Revenue Decline in Q2 2025 Amid Restructuring Efforts

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 41% Revenue Decline but Increased Net Income in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 40% Revenue Decline and $26.1 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ALLURION TECHNOLOGIES, INC. Allurion Technologies Reports 71% Revenue Decline, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments